Global Enteral Single Use Syringes Market Overview:
Enteral Single Use Syringes are widely used for administering drugs and nutritional therapy by oral, rectal and by syringes. These syringes are most commonly used in hospitals, clinics, and homes and are in the range of 1ml to 60 ml. These syringes are applied for various purpose, such as to take the correct measurement of liquid medicine to be administered to a patient and for administering medicine to infants and young children. Enteral Single Use Syringes helps in placing drugs directly into the gastrointestinal tract through the enteral route and is widely used to deliver oral liquid medication and nutrition. These syringes have a purple color plunger in order to separate these syringes from IV syringes.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Period | 2018-2023 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Adoption of ENfit in Enteral Single Use Syringes
Market Growth Drivers:
Increasing Number of Critical Care and Neonatal Intensive Care Unit, Increasing Geriatric Population Globally and Rise In Prevalence of Chronic Disorders Such As Cancer, Gastrointestinal Diseases, And Malnutrition
Challenges:
Issue Related to the Suitability for a Specific Therapeutic Area is Critical for Designing, Manufacturing, Quality, and Choice Of Syringes
Restraints:
Availability of Substitutes in Market
Opportunities:
Growing Regulatory Guidelines for the Design and Manufacture of Enteral Syringes
Competitive Landscape:
Some of the key players profiled in the report are B. Braun Melsungen (Germany), BD (United States), Cardinal Health (United States), Terumo (Japan) and Koninklijke Philips (Netherland). Additionally, following companies can also be profiled that are part of our coverage like Thermo Fisher Scientific (United States) and Enteral Single Use Syringes. Analyst at AMA Research see United States Players to retain maximum share of Global Enteral Single Use Syringes market by 2030. Considering Market by Patient Type, the sub-segment i.e. Neonates and Pediatrics will boost the Enteral Single Use Syringes market. Considering Market by Diseases Type, the sub-segment i.e. Cancer will boost the Enteral Single Use Syringes market.
Latest Market Insights:
In February 2021 Royal Philips , a global leader in health technology, today announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring. BioTelemetry’s financial results will be consolidated as part of Philips’ Connected Care business segment as of February 9, 2021.
In November 2023, Terumo India, the Indian arm of Terumo Corporation, a global leader in medical technology, announced the launch of Insulin Syringe, Sterile delivery device for patients requiring regular insulin injections, thereby raising the bar for patient comfort and therapy compliance.
According to UNFPA, UNICEF and WHO have given a policy, all countries should be using only auto-disable syringes in immunization services. Auto-disable syringes and safety boxes should be supplied in adequate quantities with all consignments of vaccines.
What Can be Explored with the Enteral Single Use Syringes Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Enteral Single Use Syringes Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Enteral Single Use Syringes
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Enteral Single Use Syringes market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Enteral Single Use Syringes market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Healthcare Industries, Pharmacists, Drugs Quality Analysts and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.